Modelling the impact of antiretroviral therapy on TB and HIV

Informal working group meeting | 4-6 November, Geneva, Switzerland

Following on the consultation on antiretroviral therapy for HIV prevention on 2-4 November 2009, this meeting considered the technical issues that arise in relation to modelling, assessing the costs, engagement with the community and consideration of human rights issues, and carrying out field trials of the impact of universal voluntary HIV testing and immediate treatment on HIV and TB.

Meeting materials



Reference articles